Search Results
Mar 10, 2026, 10:13 ET Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
cost.A Shared Vision for Growth"We are excited to partner with iGeneTech, whose expertise in gene capture and next-generation sequencing (NGS) technology enhances our strengths in gene synthesis," said Mr. Shijin Ma, CEO of Tsingke Biotech. "This partnership will speed up the translation of
More news about: Beijing Tsingke Biotech Co., Ltd.
Mar 10, 2026, 08:30 ET ePlus Ranks in Elite 150 of CRN Managed Service Provider 500 List
HERNDON, Va., March 10, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS –
More news about: EPLUS INC.
Mar 10, 2026, 05:13 ET Gene Solutions, 2. Uluslararası Kalıtsal Kanserler Kongresi 2026'da Güçlü Gerçek Dünya Kanıtları ile Türkiye Pazarına Stratejik Girişini Duyurdu
erişilebilir ve uygun fiyatlı hale getirme misyonuyla kurulmuş, Singapur merkezli küresel bir biyoteknoloji şirketidir. Multi-omik, Yeni Nesil Dizileme (NGS) ve Yapay Zeka teknolojilerinden yararlanarak, fetal ve maternal sağlık için yeni nesil prenatal tarama (triSure), çoklu kanser erken teşhisi (SPOT-MAS)
More news about: Gene Solutions Genomics Pte Ltd
Mar 05, 2026, 17:31 ET Global Companion Diagnostics Market to Register Immense Growth at a CAGR of ~12% by 2032 | DelveInsight
integration of diagnostics with therapies.Advances in Genomic Technologies: Technological improvements such as next-generation sequencing (NGS), liquid biopsy, and multiplex assays enable faster, more accurate, and cost-effective testing. Increasing Drug–Diagnostic Co-Development
More news about: DelveInsight Business Research, LLP
Mar 04, 2026, 08:00 ET Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples
the use of Next Generation Sequencing (NGS) to support viral safety strategies as an alternative to traditional in vivo tests, reflecting the potential for greater sensitivity and reduced testing time. AgentSCREEN was developed to help sponsors implement an NGS-based approach within a GMP framework,
More news about: Minaris Advanced Therapies
Mar 03, 2026, 21:00 ET Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging multi-omics, Next-Generation Sequencing (NGS), and Artificial Intelligence, the company offers a comprehensive portfolio, including next-generation prenatal screening for fetal and maternal health
More news about: Gene Solutions Genomics Pte Ltd
Mar 03, 2026, 14:36 ET Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
parallel growth avenue as health systems prioritize early detection, MRD monitoring, and treatment optimization. As the performance of liquid biopsy and NGS improves and costs decline, broader testing adoption is expected, particularly when supported by partnerships between diagnostics companies, health systems,
More news about: Credence Research Inc.
Mar 03, 2026, 10:00 ET Pillar Biosciences Launches oncoReveal® Rapid AML Panel to Support Rapid, Guideline‑Informed Genomic Insights for Acute Myeloid Leukemia
oncoReveal® Rapid AML Panel, a focused research-use-only (RUO) DNA next-generation sequencing (NGS) panel designed to help laboratories generate key acute myeloid leukemia (AML) genomic results more efficiently.
More news about: Pillar Biosciences, Inc.
Mar 03, 2026, 10:00 ET Gaia Dynamics Launches Tariff Audit Engine to Help Importers Unlock Refund Opportunities After Supreme Court IEEPA Decision
https://www.gaiadynamics.ai/.About Gaia DynamicsGaia Dynamics is an AI-driven trade technology platform founded in 2025 in partnership with Andrew Ng's AI Fund. Headquartered in Palo Alto, California, the company leverages cutting-edge artificial intelligence to simplify complex processes in tariff
More news about: Gaia Dynamics
Feb 26, 2026, 22:34 ET Volta Labs fait le buzz à AGBT 2026 avec des lancements de produits majeurs et des partenariats qui définissent l'industrie
les flux de travail modulaires et l'automatisation complète au sein d'une seule et même plateforme. Callisto™ permet une préparation de bibliothèque NGS de haute qualité et reproductible pour les applications de génome entier, ciblées et personnalisées. Le siège de Volta Labs est situé à Boston, dans
More news about: Volta Labs Inc.
Feb 26, 2026, 11:16 ET Volta Labs beflügelt die AGBT 2026 mit bedeutenden Produkteinführungen und branchenprägenden Partnerschaften
Arbeitsabläufe und vollständige Walk-Away-Automatisierung in einer einzigen Plattform kombiniert. Callisto™ ermöglicht eine hochwertige, reproduzierbare NGS-Bibliotheksvorbereitung für Ganzgenom-, gezielte und kundenspezifische Anwendungen. Volta Labs hat seinen Hauptsitz in Boston, Massachusetts.Medienkontakt:Nicole
More news about: Volta Labs Inc.
Feb 26, 2026, 09:35 ET Volta Labs impulsa AGBT 2026 con importantes lanzamientos de productos y colaboraciones
la fluídica digital, flujos de trabajo modulares y automatización completa en una única plataforma. Callisto™ permite la preparación de bibliotecas NGS de alta calidad y reproducible para aplicaciones de genoma completo, dirigidas y personalizadas. Volta Labs tiene su sede en Boston, Massachusetts.Contacto
More news about: Volta Labs Inc.
Feb 26, 2026, 09:00 ET Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
preparation by combining digital fluidics, modular workflows, and full walk-away automation in a single platform. Callisto™ enables high-quality, reproducible NGS library preparation for whole-genome, targeted, and custom applications. Volta Labs is headquartered in Boston, Massachusetts.Media Contact:Nicole
More news about: Volta Labs Inc.
Feb 26, 2026, 09:00 ET Volta Labs Ignites AGBT 2026 with Major Product Launches and Industry-Shaping Partnerships
preparation by combining digital fluidics, modular workflows, and full walk-away automation in a single platform. Callisto™ enables high-quality, reproducible NGS library preparation for whole-genome, targeted, and custom applications. Volta Labs is headquartered in Boston, Massachusetts.Media Contact:Nicole
More news about: Volta Labs Inc.
Feb 26, 2026, 08:00 ET Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™
of peripheral blood smear, and bone marrow biopsy (core and aspirate) with flow cytometry, conventional karyotyping, and next generation sequencing (NGS) with a molecular panel appropriate for age and including coverage for gene mutations expected in myeloid and lymphoid malignancies; and testing for
More news about: Orsini
Feb 25, 2026, 08:00 ET Ultima Genomics and Hamilton Partner to Automate Sample Preparation and Amplification Workflows for the Ultima Family of Sequencing Systems to Enable Improved Lab Operations and Drive Sequencing at Scale
amplification technology across Hamilton's Microlab® STAR™ liquid handling platform. The collaboration enables scalable, efficient next-generation sequencing (NGS) workflows with a simplified user experience, allowing Ultima customers to push the scale of their research and accelerate scientific discovery across
More news about: Ultima Genomics
Feb 24, 2026, 10:20 ET Clinical Microbiology Market on Track to Reach $9.7 Billion by 2033: Allied Market Research
infections and choose the appropriate treatment. Innovations in molecular diagnostics, PCR (polymerase chain reaction), and next-generation sequencing (NGS) technologies have revolutionized pathogen detection, making it faster, more accurate, and more efficient. These advancements help to identify not only
More news about: Allied Market Research
Feb 24, 2026, 08:15 ET Gilson Launches Application-Configured PIPETMAX® Systems for qPCR, NGS, and Bioassays
announced the release of its new application-configured PIPETMAX® systems, offering turnkey automation for qPCR, next-generation sequencing (NGS), and plate-based bioassays. Built around example workflows rather than open-ended programming, the new configurations make it easier for labs to adopt
More news about: Gilson
Feb 24, 2026, 08:15 ET Gilson Launches Application-Configured PIPETMAX® Systems for qPCR, NGS, and Bioassays
announced the release of its new application-configured PIPETMAX® systems, offering turnkey automation for qPCR, next-generation sequencing (NGS), and plate-based bioassays. Built around example workflows rather than open-ended programming, the new configurations make it easier for labs to adopt
More news about: Gilson
Feb 24, 2026, 08:00 ET Klotho Neurosciences (NASDAQ:KLTO) Initiates Development of the "Klotho Clock," a Diagnostic Biological Aging and Longevity Clock that Unlocks Health Testing Through Epigenetics and Artificial Intelligence (AI)
he worked at Illumina for 18 years, leading a small team of scientists developing DNA methylation and other bead-based genomics assays in addition to NGS structural variant informatics. Illumina, Inc. is a leading American biotechnology company headquartered in San Diego, specializing in the development,
More news about: Klotho Neurosciences, Inc.
Feb 23, 2026, 23:16 ET Volta Labs et Watchmaker Genomics s'associent pour présenter le kit complet Callisto™ pour la préparation des librairies ADN par EF à l'occasion d'AGBT 2026.
échantillons de séquençage de nouvelle génération (NGS), a annoncé le lancement du kit complet Callisto™ pour la préparation des bibliothèques ADN par fragmentation enzymatique (EF). La nouvelle solution associe la chimie de préparation d'échantillons NGS de Watchmaker Genomics, la meilleure de sa catégorie,
More news about: Volta Labs Inc.
Feb 23, 2026, 09:39 ET Volta Labs und Watchmaker Genomics stellen gemeinsam das Callisto™ Complete Kit für die DNA-EF-Bibliotheksvorbereitung auf der AGBT 2026 vor
Automatisierung der Probenvorbereitung für die Next-Generation-Sequencing (NGS), heute die Einführung des Callisto™ Complete Kit für die DNA-EF-Bibliotheksvorbereitung bekannt. Die neue Lösung kombiniert die branchenführende NGS-Probenvorbereitung von Watchmaker Genomics mit der digitalen Fluidik-Automatisierung
More news about: Volta Labs Inc.
Feb 23, 2026, 09:01 ET Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Orlando, FL, Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep. The new solution pairs Watchmaker Genomics' best-in-class NGS sample preparation chemistry with Volta's digital fluidics automation
More news about: Volta Labs Inc.
Feb 23, 2026, 09:01 ET Volta Labs and Watchmaker Genomics Partner to Introduce Callisto™ Complete Kit for DNA EF Library Prep at AGBT 2026
Orlando, FL, Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto™ Complete Kit for DNA EF Library Prep. The new solution pairs Watchmaker Genomics' best-in-class NGS sample preparation chemistry with Volta's digital fluidics automation
More news about: Volta Labs Inc.
Feb 23, 2026, 09:01 ET Volta Labs y Watchmaker Genomics se asocian para presentar el kit completo Callisto™
preparación de muestras para secuenciación de próxima generación (NGS), anunció hoy el lanzamiento del kit completo Callisto™ para la preparación de bibliotecas de ADN EF. Esta nueva solución combina la química de preparación de muestras NGS de Watchmaker Genomics, líder en su clase, con la automatización
More news about: Volta Labs Inc.